Veracyte has entered into a definitive agreement to sell approximately $40 million of its common stock in a private placement
Category | Financing
Dimension Therapeutics snags series B for $65mn
Posted on 22 April 2015
Dimension Therapeutics announced the successful completion of a Series B financing totaling $65 million
Innocrin raises $28 million in series D financing
Posted on 15 April 2015
Innocrin Pharmaceuticals announced the completion of a $28 million Series D financing round
Mesoblast banks $45mn financing from Celgene
Posted on 14 April 2015
Mesoblast has entered into an Agreement with Celgene
Edge Therapeutics bags $56mn series C2
Posted on 13 April 2015
Edge Therapeutics has raised approximately $72.5 million in gross proceeds from two recently completed private financing rounds
Natera raises $55mn private placement
Posted on 09 April 2015
Natera has raised approximately $55.5 million in funding led by Silicon Valley life sciences investment firm Sofinnova Ventures
Nabriva banks $120mn series B
Posted on 09 April 2015
Nabriva Therapeutics announced the successful completion of a $120 million Series B financing
True North Therapeutics banks $32mn series B
Posted on 09 April 2015
True North Therapeutics has completed a $35 million Series B equity financing
Thrasos bags $21 million financing led by SR One
Posted on 01 April 2015
Thrasos Therapeutics has completed a $21M Series D financing led by BDC Capital and SR One
Immunogen gains $200 million from Kadcyla royalty financing
Posted on 31 March 2015
ImmunoGen announced a $200 million non-dilutive royalty transaction with funds managed by TPG Special Situations Partners
